Category Archives: Genomic Methodology

ToxicoGenomica

2023 Brings Multiple Waves Of Additional Studies Regarding Mesotheliomas And Other Cancers Caused Solely By Genomic Factors

| September 5, 2023

ToxicoGenomica recently presented a webinar organized by Perrin Conferences and the slides are now available for download. The webinar focused on the latest publications, scientific studies, and statistics regarding genomics role in cancers. It also covered predictive software and other tools for understanding the impact of germline mutations on disease development and progression. The speakers […]

Learn More

Upcoming Perrin Conference on Cutting-Edge Issues in Asbestos Litigation: Beverly Hills, CA

| March 3, 2022

The use of genomic analysis to evaluate mesothelioma causation is a topic that will be covered at the upcoming Perrin Conference on Cutting-Edge Issues in Asbestos Litigation. As part of a panel, ToxicoGenomica’s Kirk Hartley will discuss several topics at the intersections between genomic science and law. One portion of his talk will focus on […]

Learn More
mid atlantic conference

The Science & Medicine of Genetic Testing in Asbestos and Talc Cases

| July 22, 2019

As we have written over the past few years, expert testimony involving genetic findings is becoming more and more common in asbestos litigation. As we wrote previously, on Wednesday, July 17 (2019) Dr. Len van Zyl of ToxicoGenomica presented at the Perrin Mid-Atlantic Asbestos Conference where he discussed important new emerging science relevant to the […]

Learn More
Litigators Guide to a Genomic Defense

The Litigator’s Guide to Using Genomics in a Toxic Tort Case

| June 11, 2018

Genomics is a proven and reliable quantitative tool that has dramatically improved cancer treatment, established the practice of personalized medicine, and brought binary clarity to paternity and criminal cases. Genomics is now transforming how civil toxic tort cases are adjudicated. We have hit a tipping point where, instead of merely relying on population-based epidemiological studies, […]

Learn More
Predisposition vs Susceptibility

What is the Difference Between Predisposition and Susceptibility in a Toxic Tort Case?

| May 7, 2018

As the application of genomic sciences becomes common in toxic tort litigation, savvy litigators are occasionally concerned about whether genomic information may backfire on the defense or the plaintiff. For example, defense lawyers may worry that plaintiff’s counsel may argue that an exposure to a minute amount of a toxicant caused an injury through an […]

Learn More
Scientist looking at DNA

Some Important Factors to Consider When Using Genomic Science in Toxic Tort Litigation

| April 30, 2018

As the application of genomic science becomes more common in toxic tort litigation, savvy litigators are thinking about how statements about genetic findings may fit into legal categories or terms of art. In our view, non-scientists need to keep in mind that words used as terms of art for genetic findings are not necessarily equivalent […]

Learn More
Taq polymerase PCR enzyme

Protein-Based Adverse Drug Reactions (ADRs): Using Proteomics to Assess Drug Safety

| February 26, 2018

Each year, adverse drug events cost millions of dollars in hospital admissions, injuries to patients, and malpractice. And companies spend billions of dollars on litigation involving allegations that their drugs caused adverse drug reactions (ADRs). What if there was a better way to determine individualized drug adverse events? Welcome to the Age of Proteomics The […]

Learn More
Genetic testing concept, DNA icon, medical doctor, isolated on white

5 Toxic Tort Cases Where Genomic Science Was Successfully Applied

| September 11, 2017

To avoid needless ethical and/or legal disputes and to avoid wasting time and money, it’s important to think about genomic issues early on in a case. It’s also useful to look across sets of cases to get a clearer understanding of how genomics can provide an effective strategy. In general, it’s desirable and cost-effective to […]

Learn More